Your browser doesn't support javascript.
loading
Targeting BMI1 mitigates chemoresistance in ovarian cancer.
Dey, Anindya; Dhar Dwivedi, Shailendra Kumar; Wang, Lin; Hossen, Md Nazir; Neizer-Ashun, Fiifi; Bieniasz, Magdalena; Mukherjee, Priyabrata; Baird, John D; Weetall, Marla; Bhattacharya, Resham.
Afiliación
  • Dey A; Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
  • Dhar Dwivedi SK; Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
  • Wang L; Department of Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
  • Hossen MN; Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
  • Neizer-Ashun F; Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, California Northstate University, Elk Grove, CA 95757, USA.
  • Bieniasz M; Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
  • Mukherjee P; Department of Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
  • Baird JD; Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
  • Weetall M; Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
  • Bhattacharya R; PTC Therapeutics, Inc, South Plainfield, NJ 07080, USA.
Genes Dis ; 9(6): 1415-1418, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36157476

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Genes Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Genes Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
...